Table 1.
Baseline Characteristics of the Study Sample
| Treatment Group (n=38) %/Mean(SD) |
Control Group (n=33) %/Mean(SD) |
Total (n=71) %/Mean(SD) |
p-value | Min | Max | |
|---|---|---|---|---|---|---|
| Age | 85.0 (5.2) | 85.0 (5.8) | 85.0 (5.4) | .96 | 65 | 95 |
| Gender (% female) | 63.2% | 60.6% | 62.0% | .82 | --- | --- |
| Race (% Caucasian) | 100% | 100% | 100% | -- | --- | --- |
| CDR Score | 1.2 (0.5) | 1.3 (0.6) | 1.3 (0.6) | .96 | 0.5 | 2.0 |
| MBDRS Score | 6.2 (2.7) | 7.1 (2.4) | 6.6 (2.6) | .14 | 3.0 | 13.0 |
| MMSE | 13.8 (7.0) | 13.1 (5.3) | 13.5 (6.2) | .63 | 0 | 30 |
| LEQ Score | 70.0 (15.2) | 68.5 (15.6) | 69.3 (15.3) | .68 | 38.8 | 117.5 |
| ApoE ε4 (% no ε4) | 68.4% | 64.5% | 66.7% | .34 | 0 | 2 |
| Charlson | 2.8 (1.5) | 2.8 (1.4) | 2.8 (1.5) | .97 | 1 | 6 |
CDR = Clinical Dementia Rating; MBDRS = Modified Blessed Dementia Rating Scale; LEQ = Lifetime of Experiences Questionnaire; Charlson = Charlson Co-Morbidity Index; MMSE = Mini-Mental State Examination; SD = standard deviation.